AXA SA (CS.PA) Stock Fundamental Analysis

EPA:CS • FR0000120628

41.46 EUR
+0.6 (+1.47%)
Last: Feb 27, 2026, 07:00 PM
Fundamental Rating

5

Overall CS gets a fundamental rating of 5 out of 10. We evaluated CS against 46 industry peers in the Insurance industry. CS has an average financial health and profitability rating. CS has a decent growth rate and is not valued too expensively. Finally CS also has an excellent dividend rating. These ratings could make CS a good candidate for dividend investing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • CS had positive earnings in the past year.
  • In the past year CS had a positive cash flow from operations.
  • In the past 5 years CS has always been profitable.
  • In the past 5 years CS always reported a positive cash flow from operatings.
CS.PA Yearly Net Income VS EBIT VS OCF VS FCFCS.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

1.2 Ratios

  • CS's Return On Assets of 1.18% is in line compared to the rest of the industry. CS outperforms 43.48% of its industry peers.
  • Looking at the Return On Equity, with a value of 16.72%, CS is in the better half of the industry, outperforming 67.39% of the companies in the same industry.
  • CS has a Return On Invested Capital of 1.28%. This is comparable to the rest of the industry: CS outperforms 56.52% of its industry peers.
  • CS had an Average Return On Invested Capital over the past 3 years of 1.29%. This is in line with the industry average of 3.04%.
Industry RankSector Rank
ROA 1.18%
ROE 16.72%
ROIC 1.28%
ROA(3y)1.09%
ROA(5y)0.91%
ROE(3y)14.54%
ROE(5y)11.55%
ROIC(3y)1.29%
ROIC(5y)1.11%
CS.PA Yearly ROA, ROE, ROICCS.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • The Profit Margin of CS (8.52%) is comparable to the rest of the industry.
  • In the last couple of years the Profit Margin of CS has grown nicely.
  • CS has a Operating Margin (11.47%) which is comparable to the rest of the industry.
  • In the last couple of years the Operating Margin of CS has grown nicely.
Industry RankSector Rank
OM 11.47%
PM (TTM) 8.52%
GM N/A
OM growth 3Y15.12%
OM growth 5Y20.23%
PM growth 3Y14.87%
PM growth 5Y26.69%
GM growth 3YN/A
GM growth 5YN/A
CS.PA Yearly Profit, Operating, Gross MarginsCS.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

5

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CS is destroying value.
  • Compared to 1 year ago, CS has less shares outstanding
  • CS has less shares outstanding than it did 5 years ago.
  • CS has a worse debt/assets ratio than last year.
CS.PA Yearly Shares OutstandingCS.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B
CS.PA Yearly Total Debt VS Total AssetsCS.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200B 400B 600B 800B

2.2 Solvency

  • Based on the Altman-Z score of 0.35, we must say that CS is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 0.35, CS belongs to the top of the industry, outperforming 86.96% of the companies in the same industry.
  • CS has a debt to FCF ratio of 1.41. This is a very positive value and a sign of high solvency as it would only need 1.41 years to pay back of all of its debts.
  • CS's Debt to FCF ratio of 1.41 is fine compared to the rest of the industry. CS outperforms 73.91% of its industry peers.
  • A Debt/Equity ratio of 0.65 indicates that CS is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.65, CS perfoms like the industry average, outperforming 47.83% of the companies in the same industry.
  • Even though the debt/equity ratio score it not favorable for CS, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 1.41
Altman-Z 0.35
ROIC/WACC0.12
WACC10.78%
CS.PA Yearly LT Debt VS Equity VS FCFCS.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.3 Liquidity

  • CS has a Current Ratio of 0.82. This is a bad value and indicates that CS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CS has a better Current ratio (0.82) than 84.78% of its industry peers.
  • A Quick Ratio of 0.82 indicates that CS may have some problems paying its short term obligations.
  • CS has a better Quick ratio (0.82) than 84.78% of its industry peers.
Industry RankSector Rank
Current Ratio 0.82
Quick Ratio 0.82
CS.PA Yearly Current Assets VS Current LiabilitesCS.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

4

3. Growth

3.1 Past

  • CS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.70%, which is quite good.
  • The Earnings Per Share has been growing by 18.09% on average over the past years. This is quite good.
  • The Revenue has been growing slightly by 4.40% in the past year.
  • Measured over the past years, CS shows a decrease in Revenue. The Revenue has been decreasing by -8.16% on average per year.
EPS 1Y (TTM)8.7%
EPS 3Y9.29%
EPS 5Y18.09%
EPS Q2Q%8.56%
Revenue 1Y (TTM)4.4%
Revenue growth 3Y-10.62%
Revenue growth 5Y-8.16%
Sales Q2Q%3.72%

3.2 Future

  • Based on estimates for the next years, CS will show a small growth in Earnings Per Share. The EPS will grow by 6.91% on average per year.
  • The Revenue is expected to grow by 8.17% on average over the next years. This is quite good.
EPS Next Y12.2%
EPS Next 2Y9.08%
EPS Next 3Y8.44%
EPS Next 5Y6.91%
Revenue Next Year8.42%
Revenue Next 2Y6.56%
Revenue Next 3Y6.39%
Revenue Next 5Y8.17%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CS.PA Yearly Revenue VS EstimatesCS.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 20B 40B 60B 80B 100B
CS.PA Yearly EPS VS EstimatesCS.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1 2 3 4 5

6

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 11.06, the valuation of CS can be described as reasonable.
  • 76.09% of the companies in the same industry are more expensive than CS, based on the Price/Earnings ratio.
  • The average S&P500 Price/Earnings ratio is at 27.07. CS is valued rather cheaply when compared to this.
  • With a Price/Forward Earnings ratio of 9.71, the valuation of CS can be described as very reasonable.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of CS indicates a somewhat cheap valuation: CS is cheaper than 78.26% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 28.05. CS is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 11.06
Fwd PE 9.71
CS.PA Price Earnings VS Forward Price EarningsCS.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 89.13% of the companies in the same industry are more expensive than CS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 4.14
EV/EBITDA N/A
CS.PA Per share dataCS.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.91
PEG (5Y)0.61
EPS Next 2Y9.08%
EPS Next 3Y8.44%

7

5. Dividend

5.1 Amount

  • CS has a Yearly Dividend Yield of 5.68%, which is a nice return.
  • CS's Dividend Yield is rather good when compared to the industry average which is at 4.03. CS pays more dividend than 80.43% of the companies in the same industry.
  • CS's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 5.68%

5.2 History

  • The dividend of CS is nicely growing with an annual growth rate of 8.12%!
Dividend Growth(5Y)8.12%
Div Incr Years4
Div Non Decr Years4
CS.PA Yearly Dividends per shareCS.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2 2.5

5.3 Sustainability

  • 61.79% of the earnings are spent on dividend by CS. This is not a sustainable payout ratio.
  • The dividend of CS is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP61.79%
EPS Next 2Y9.08%
EPS Next 3Y8.44%
CS.PA Yearly Income VS Free CF VS DividendCS.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B
CS.PA Dividend Payout.CS.PA Dividend Payout, showing the Payout Ratio.CS.PA Dividend Payout.PayoutRetained Earnings

AXA SA

EPA:CS (2/27/2026, 7:00:00 PM)

41.46

+0.6 (+1.47%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)02-26
Earnings (Next)07-30
Inst Owners40.46%
Inst Owner ChangeN/A
Ins Owners0.1%
Ins Owner ChangeN/A
Market Cap86.68B
Revenue(TTM)89.27B
Net Income(TTM)7.61B
Analysts82.76
Price Target45.98 (10.9%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.68%
Yearly Dividend2.02
Dividend Growth(5Y)8.12%
DP61.79%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.91%
PT rev (3m)1.36%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0.02%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.62%
Revenue NY rev (3m)-0.72%
Valuation
Industry RankSector Rank
PE 11.06
Fwd PE 9.71
P/S 0.97
P/FCF 4.14
P/OCF 4.05
P/B 1.91
P/tB 3.6
EV/EBITDA N/A
EPS(TTM)3.75
EY9.04%
EPS(NY)4.27
Fwd EY10.3%
FCF(TTM)10.01
FCFY24.14%
OCF(TTM)10.24
OCFY24.69%
SpS42.7
BVpS21.76
TBVpS11.53
PEG (NY)0.91
PEG (5Y)0.61
Graham Number42.85
Profitability
Industry RankSector Rank
ROA 1.18%
ROE 16.72%
ROCE 1.62%
ROIC 1.28%
ROICexc 1.33%
ROICexgc 1.74%
OM 11.47%
PM (TTM) 8.52%
GM N/A
FCFM 23.44%
ROA(3y)1.09%
ROA(5y)0.91%
ROE(3y)14.54%
ROE(5y)11.55%
ROIC(3y)1.29%
ROIC(5y)1.11%
ROICexc(3y)1.34%
ROICexc(5y)1.16%
ROICexgc(3y)1.75%
ROICexgc(5y)1.48%
ROCE(3y)1.62%
ROCE(5y)1.41%
ROICexgc growth 3Y10.47%
ROICexgc growth 5Y16.55%
ROICexc growth 3Y8.69%
ROICexc growth 5Y14.36%
OM growth 3Y15.12%
OM growth 5Y20.23%
PM growth 3Y14.87%
PM growth 5Y26.69%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 1.41
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 0.53%
Interest Coverage 1.98
Cash Conversion N/A
Profit Quality 275.1%
Current Ratio 0.82
Quick Ratio 0.82
Altman-Z 0.35
F-Score7
WACC10.78%
ROIC/WACC0.12
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.46%
Cap/Sales(5y)0.4%
Profit Quality(3y)104.89%
Profit Quality(5y)238.88%
High Growth Momentum
Growth
EPS 1Y (TTM)8.7%
EPS 3Y9.29%
EPS 5Y18.09%
EPS Q2Q%8.56%
EPS Next Y12.2%
EPS Next 2Y9.08%
EPS Next 3Y8.44%
EPS Next 5Y6.91%
Revenue 1Y (TTM)4.4%
Revenue growth 3Y-10.62%
Revenue growth 5Y-8.16%
Sales Q2Q%3.72%
Revenue Next Year8.42%
Revenue Next 2Y6.56%
Revenue Next 3Y6.39%
Revenue Next 5Y8.17%
EBIT growth 1Y7.05%
EBIT growth 3Y2.9%
EBIT growth 5Y10.41%
EBIT Next Year26.98%
EBIT Next 3Y11.3%
EBIT Next 5YN/A
FCF growth 1Y150.74%
FCF growth 3Y7.74%
FCF growth 5Y9.94%
OCF growth 1Y145.39%
OCF growth 3Y7.85%
OCF growth 5Y9.48%

AXA SA / CS.PA FAQ

What is the ChartMill fundamental rating of AXA SA (CS.PA) stock?

ChartMill assigns a fundamental rating of 5 / 10 to CS.PA.


What is the valuation status of AXA SA (CS.PA) stock?

ChartMill assigns a valuation rating of 6 / 10 to AXA SA (CS.PA). This can be considered as Fairly Valued.


What is the profitability of CS stock?

AXA SA (CS.PA) has a profitability rating of 5 / 10.


Can you provide the PE and PB ratios for CS stock?

The Price/Earnings (PE) ratio for AXA SA (CS.PA) is 11.06 and the Price/Book (PB) ratio is 1.91.


What is the financial health of AXA SA (CS.PA) stock?

The financial health rating of AXA SA (CS.PA) is 5 / 10.